Actualités Encysive Pharmaceuticals (MM) - ENCY | Actions NASDAQ

Encysive Pharmaceuticals Inc- (25-NSE)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 25 NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION...

Pfizer Completes Acquisition of Encysive Pharmaceuticals Inc.

Pfizer Inc (NYSE:PFE) today announced that it has completed the acquisition of all remaining outstanding shares of common stock...

Encysive Pharmaceuticals Inc - Quarterly Report (10-Q)

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ...

Encysive Pharmaceuticals Inc - Schedule 13G

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment...

Encysive Pharmaceuticals Inc - Tender offer statement by Issuer (SC TO-I)

Table of Contents SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE TO (Rule 14d-100) TENDER OFFER...

Encysive Pharmaceuticals Inc - Information Statement - Merger or Acquisition (preliminary) (PREM14C)

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ...

Encysive Pharmaceuticals Inc - Amended Statement of Beneficial Ownership (SC 13D/A)

...

Encysive Pharmaceuticals Inc - Amended Statement of Ownership: Solicitation (SC 14D9/A)

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14D-9 (RULE 14d-101) SOLICITATION/RECOMMENDATION...

Encysive Pharmaceuticals Inc - Amended tender offer statement by Third Party (SC TO-T/A)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE TO/A Tender Offer Statement under Section 14(d)(1) or...

Encysive Pharmaceuticals Inc - Statement of Beneficial Ownership (SC 13D)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D UNDER THE SECURITIES EXCHANGE ACT OF 1934 ENCYSIVE...

Encysive Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

Encysive Pharmaceuticals Inc - Schedule 13G

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment...

Encysive Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

Encysive Pharmaceuticals Inc - Amended Statement of Ownership: Solicitation (SC 14D9/A)

Table of Contents SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14D-9 (RULE 14d-101...

Encysive Pharmaceuticals Inc - Amended tender offer statement by Third Party (SC TO-T/A)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE TO/A Tender Offer Statement under Section 14(d)(1) or...

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Encysive Pharmaceuticals (MM) (ENCY)

Outils de qualité professionnelle, pour des investisseurs individuels.

ENCY Actualités

Encysive Pharmaceuticals Inc- (25-NSE)

Pfizer Completes Acquisition of Encysive Pharmaceuticals Inc.

Encysive Pharmaceuticals Inc - Quarterly Report (10-Q)

Encysive Pharmaceuticals Inc - Schedule 13G

Encysive Pharmaceuticals Inc - Tender offer statement by Issuer (SC TO-I)

Encysive Pharmaceuticals Inc - Information Statement - Merger or Acquisition (preliminary) (PREM14C)

Encysive Pharmaceuticals Inc - Amended Statement of Beneficial Ownership (SC 13D/A)

Encysive Pharmaceuticals Inc - Amended Statement of Ownership: Solicitation (SC 14D9/A)

Encysive Pharmaceuticals Inc - Amended tender offer statement by Third Party (SC TO-T/A)

Encysive Pharmaceuticals Inc - Statement of Beneficial Ownership (SC 13D)

Encysive Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4)

Encysive Pharmaceuticals Inc - Schedule 13G

Encysive Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4)

Encysive Pharmaceuticals Inc - Amended Statement of Ownership: Solicitation (SC 14D9/A)

Encysive Pharmaceuticals Inc - Amended tender offer statement by Third Party (SC TO-T/A)

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Encysive Pharmaceuticals (MM) (ENCY) Actualités

Encysive Pharmaceuticals (MM) (ENCY)

Outils de qualité professionnelle, pour des investisseurs individuels.

ENCY Actualités

Encysive Pharmaceuticals Inc- (25-NSE)

Pfizer Completes Acquisition of Encysive Pharmaceuticals Inc.

Encysive Pharmaceuticals Inc - Quarterly Report (10-Q)

Encysive Pharmaceuticals Inc - Schedule 13G

Encysive Pharmaceuticals Inc - Tender offer statement by Issuer (SC TO-I)

Encysive Pharmaceuticals Inc - Information Statement - Merger or Acquisition (preliminary) (PREM14C)

Encysive Pharmaceuticals Inc - Amended Statement of Beneficial Ownership (SC 13D/A)

Encysive Pharmaceuticals Inc - Amended Statement of Ownership: Solicitation (SC 14D9/A)

Encysive Pharmaceuticals Inc - Amended tender offer statement by Third Party (SC TO-T/A)

Encysive Pharmaceuticals Inc - Statement of Beneficial Ownership (SC 13D)

Encysive Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4)

Encysive Pharmaceuticals Inc - Schedule 13G

Encysive Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4)

Encysive Pharmaceuticals Inc - Amended Statement of Ownership: Solicitation (SC 14D9/A)

Encysive Pharmaceuticals Inc - Amended tender offer statement by Third Party (SC TO-T/A)

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités